Bill Text: NY A00587 | 2017-2018 | General Assembly | Amended

Bill Title: Requires urine polymerase chain reaction testing for cytomegalovirus of newborns with hearing impairments; and directs the department of health to establish an education program for women who may become pregnant, expectant parents and parents of infants relating to various aspects of cytomegalovirus.

Spectrum: Moderate Partisan Bill (Democrat 24-4)

Status: (Introduced) 2018-03-13 - reported referred to ways and means [A00587 Detail]

Download: New_York-2017-A00587-Amended.html

                STATE OF NEW YORK
                               2017-2018 Regular Sessions
                   IN ASSEMBLY
                                     January 9, 2017
        Introduced  by  M.  of  A. L. ROSENTHAL, ORTIZ, ZEBROWSKI, SANTABARBARA,
          HARRIS, JENNE, RAIA -- Multi-Sponsored by -- M. of A. BUCHWALD, ENGLE-
          read once and  referred  to  the  Committee  on  Health  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee -- recommitted to the Committee on Health in accord-
          ance  with  Assembly  Rule  3,  sec.  2  -- committee discharged, bill
          amended, ordered reprinted as amended and recommitted to said  commit-
          tee  --  again  reported  from said committee with amendments, ordered
          reprinted as amended and recommitted to said committee
        AN ACT to amend the public health law, in relation  to  the  testing  of
          certain newborns for cytomegalovirus and public education thereon
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. Subdivision (a) of section 2500-a of the public health law,
     2  as amended by chapter 184 of the laws of 2013, is  amended  to  read  as
     3  follows:
     4    (a)  1.  It  shall  be the duty of the administrative officer or other
     5  person in charge of each institution  caring  for  infants  twenty-eight
     6  days  or  less  of  age  and  the  person  required  in pursuance of the
     7  provisions of section forty-one hundred thirty of this chapter to regis-
     8  ter the birth of a child, to cause to have administered  to  every  such
     9  infant or child in its or his care a test for:
    10    i. phenylketonuria,
    11    ii. homozygous sickle cell disease,
    12    iii. hypothyroidism,
    13    iv. branched-chain ketonuria,
    14    v. galactosemia,
    15    vi. homocystinuria,
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.

        A. 587--C                           2
     1    vii.  critical congenital heart defects through pulse oximetry screen-
     2  ing, [and]
     3    viii.  with  regard  to  any  newborn  infant who is identified as, or
     4  suspected of, having a hearing impairment as a  result  of  a  screening
     5  conducted pursuant to section twenty-five hundred-g of this title, cause
     6  to  be  administered  to  such  infant a urine polymerase chain reaction
     7  (PCR) test for cytomegalovirus, unless the parent of the infant  objects
     8  thereto;  provided that if the commissioner determines that another test
     9  for cytomegalovirus is diagnostically equivalent to or better  than  the
    10  urine  polymerase  chain  reaction  test, the commissioner may, by regu-
    11  lation under this section, allow or require the use of that other  test,
    12  and
    13    ix.  such  other  diseases  and conditions as may from time to time be
    14  designated by the commissioner in accordance with rules  or  regulations
    15  prescribed by the commissioner.
    16    2.  Testing,  the  recording  of  the results of such tests, tracking,
    17  follow-up reviews and educational activities shall be performed at  such
    18  times  and  in such manner as may be prescribed by the commissioner. The
    19  commissioner shall promulgate regulations setting forth  the  manner  in
    20  which  information  describing  the purposes of the requirements of this
    21  section shall be disseminated to parents or a  guardian  of  the  infant
    22  tested.
    23    §  2. Subdivision 1 of section 207 of the public health law is amended
    24  by adding a new paragraph (o) to read as follows:
    25    (o) For women who may become pregnant, expectant parents  and  parents
    26  of infants, information regarding:
    27    (i) the incidence of cytomegalovirus;
    28    (ii)  the  transmission and risks of cytomegalovirus to pregnant women
    29  and women who may become pregnant;
    30    (iii) birth defects caused by congenital cytomegalovirus;
    31    (iv) methods of diagnosing congenital cytomegalovirus;
    32    (v) the available preventive measures to avoid the infection of  women
    33  who are pregnant or may become pregnant; and
    34    (vi)  available  methods  of  treating  cytomegalovirus  and resources
    35  available for families of children born with cytomegalovirus.
    36    § 3. This act shall take effect immediately; provided,  however,  that
    37  section  one  of this act shall take effect on the one hundred twentieth
    38  day after it shall have become a law. Effective immediately,  the  addi-
    39  tion,  amendment  and/or  repeal of any rule or regulation necessary for
    40  the implementation of section one of this act on its effective date  are
    41  authorized  and  directed  to  be  made  and completed on or before such
    42  effective date.